title: Rare phenomenon: liver metastases from glioblastoma multiforme.
authors.affiliation: University Hospital Ulm, Ulm, Germany.
authors.forename: Stefan S
authors.initials: SS
authors.lastname: Schönsteiner
authors.forename: Martin
authors.initials: M
authors.lastname: Bommer
authors.forename: Mark M
authors.initials: MM
authors.lastname: Haenle
authors.forename: Beate
authors.initials: B
authors.lastname: Klaus
authors.forename: Angelika
authors.initials: A
authors.lastname: Scheuerle
authors.forename: Mathias
authors.initials: M
authors.lastname: Schmid
authors.forename: Regine
authors.initials: R
authors.lastname: Mayer-Steinacker
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000068258:Bevacizumab; D014408:Biomarkers, Tumor / Q000032:analysis; D001932:Brain Neoplasms / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005909:Glioblastoma / Q000378:metabolism / Q000556:secondary* / Q000628:therapy; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000378:metabolism / Q000556:secondary*; D008297:Male; D011878:Radiotherapy; D000077204:Temozolomide
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D000068258:Bevacizumab; D003606:Dacarbazine; D000077204:Temozolomide